An asthmatic patient developed intense bronchospasm immediately following the administration of alcuronium and d-tubocurarine in the same anaesthetic. Intradermal test was positive for both of these drugs but negative for thiopentone and suxamethonium, both of which were given prior to alcuronium. The differential diagnosis and the possible mechanism of the reaction are discussed.
INTRODUCTION
Since the first report of a major reaction to alcuronium by Chan and Yeung (1972) several others have appeared in the literature (Rowley 1975, Fisher, HalIowes and Wilson 1978) . All of these cases involved cardiovascular collapse. There is no report in the literature of bronchospasm alone due to alcuronium although Heath (1973) mentioned that such cases had been reported to the Committee on Safety of Medicines. Tubocurarine has been shown to release histamine (Alam et al. 1939 , Comroe and Dripps 1946 , Sniper 1952 , Salem, Kim and El Etr 1968 and Landmesser (1947) attributed bronchoconstriction in the dog following administration of curare to histamine release. But in clinical practice bronchospasm due to tubocurarine is rare (Heath 1973) and Gray (1971) has not found histamine release a hazard even in asthmatic patients. We report here the occurrence of severe bronchospasm in an asthmatic patient following the administration of alcuronium and d-tubocurarine in the same anaesthetic.
Case Report
A 21-year-old woman weighing 43 kg who had had no previous anaesthesia was admitted with ruptured ectopic pregnancy. The blood pressure was 100/60 mm Hg, and pulse rate 100 beats/min. Her haemoglobin was 12.5 g/ dl. She gave a history of bronchial asthma for about five years, but had been free of symptoms in the recent summer months and was not taking any medication. Chest expansion was normal and rhonchi were absent. She was given atropine 0.6 mg and pethidine 50 mg as premedication 30 minutes before induction. The blood pressure and pulse rate prior to induction were 120/80 mm Hg and 100 beats/min respectively. Anaesthesia was induced with thiopentone 175 mg followed by suxamethonium 50 mg to facilitate tracheal intubation. IPPV was started with 5 litres of nitrous oxide and 2.5 litres of oxygen per minute, using a Manley ventilator. The tidal volume was set at 600 ml (checked with a Wright respirometer) and the inflating pressure 20 cm of water. The gynaecologist started to operate. When muscle tone returned 5-6 minutes after induction alcuronium 10 mg was given intravenously. Within 30 seconds after the injection difficulty of inflating the lungs was apparent even after setting the inflating pressure at the maximum of 35 cm of water. Auscultation revealed complete absence of breath sounds on both sides. The Anaesthesia and Intensive Care, Vol. Vll, No. I, Februarr, 1979 ventilator was switched to the manual mode and 100% oxygen used. It was impossible to squeeze any gas into the lungs. Passage of a suction catheter demonstrated no obstruction within the endotracheal tube. Terbutaline (Bricanyl) '0.25 mg diluted to 10 ml with water was given slowly intravenously. Inflation gradually became easier over about two minutes. Rhonchi especially during expiration could now be heard on auscultation. The ventilator was switched back to the automatic mode at a pressure of 3D cm of water and nitrous oxide reintroduced. Over the next five minutes wheezing had diminished markedly, and only occasional rhonchi were heard. The inflating pressure could then be reduced back to 2'0 cm of water. During the episode the blood pressure had been maintained between 1'0'0/6'0 and 12'0/8'0 mm Hg although tachycardia was present.
Ten minutes after vhis episode the abdominal muscle relaxation was inadequate. A test dose of alcuronium 1 mg was given. Bronchospasm returned almost immediately though with less intensity. This was relieved by '0.1 mg of terbutaline. It was decided not to give more alcuronium. As we were short of supply of pancuronium d-tubocurarine 3 mg was given. Again bronchospasm returned immediately, which fortunately was relieved by another dose of terbutaline 0.15 mg.
The operation, which took 45 minutes, went on uneventfully with right salpingectomy performed. The total blood loss including 15'0 ml in the peritoneal cavity was 2'0'0-25'0 ml. Five hundred ml of normal saline but no blood was given during operation. Throughout the operation there had been no sign of lightness of anaesthesia. Muscle relaxant reversal with neostigmine 2.5 mg and atropine 1.2 mg was achieved without difficulty. Although occasional rhonchi persisted for about 3D minutes after operation the postoperative period was uneventful.
We intended to do some tests in three months time including the intradermal test advocated by Fisher (1976) , and the FEV 1 before and after intravenous injection of a very small dose (e.g., 1:1'0'0,'00'0) of the suspected drugs. As many patients in this community are defaulters at follow-up we decided to do such tests before discharge and to repeat them in three months if the patient returned. In this case the patient quite justifiably refused to perform the FEV 1 test because of the abdominal wound. Intradermal tests were done 7 days postoperatively with normal saline and 1: 10'0'0 dilution of the following: thiopentone 2.5%, suxamethonium 5'0 mg/ml, alcuronium 5 mg/ ml, and d-tubocurarine ID mg/ml. Positive results were obtained with alcuronium and d-tubocurarine according to Fisher's criteria (1976) . The patient did not return for follow up at three months. However, she had been cautioned against further exposure to both alcuronium and d-tubocurarine.
DISCUSSION
Bronchospasm may be evoked by thiopentone when certain predisposing conditions are present (Dundee 1971, Lee and Atkinson 1975) , and it may also occur as part of a sensitivity reaction to thiopentone (Anderton and Hopton 1968, Chung 1976) . In most cases of sensitivity to suxamethonium bronchospasm has been the main feature (Bele-Binda and Valeri 1971 , Eustace 1967 , Katz and Mulligan 1972 . In the present case the first attack of bronchospasm might have been attributed to any of the drugs given at that point, i.e., thiopentone, suxamethonium, and alcuronium. However, in the second and third episodes it is highly unlikely that either thiopentone or suxamethonium was responsible as at least 15 minutes had elapsed after injection. That alcuronium and d-tubocurarine had been the cause is funher suggested by the positive intradermal test. Although such test performed during the "refractory" period after a reaction may not be reliable, one would have expected a false negative (Fisher 1967) rather than a false positive result. It may still be argued that the negative results to thiopentone and suxamethonium were false and that therefore the patient was sensitive to either or bovh in addition to alcuronium and d-tubocurarine. We think that this situation is highly conjectural and unlikely. Had the patient been co-operative further testing in three months, especially the FEV 1 before and after a small intravenous dose, would have settled the problem.
The bronohospasm is probably due to the action of histamine on the hyper-reactive bronchial musculature of an asthmatic patient (Howell 1975) . Histamine may be released directly by a drug or via some immune mechanism (Watkins et al. 1976 ) but it is difficult to incriminate any particular mechanism without elaborate tests which are not available in most hospitals. While d-tubocurarine is reputed for its histamine releasing properties alcuronium is not (Waser and Harbeck 1962) . This patient may be an exception in that histamine is released directly by alcuronium as well as by d-tubocurarine. As the reaction followed almost immediately after injection it is unlikely that histamine release had been mediated via chemical activation of complement C 3 • On the other hand, it is possible, despite the absence of a previous exposure and other features of anaphylactic shock, that the reaction has been a true anaphylaxis, the patient being sensitive to borh alcuronium and d-tubocurarine which are similar in structure .
Either pancuronium or gallamine might have been a better choice as a substitute for alcuronium in this patient although reactions including bronchospasm due to these drugs have been reported (Buckland and Avery 1973 , Clarke 1973 , Heath 1973 , Watt 1973 .
Various drugs have been advocated for the treatment of bronchospasm during anaesthesia, e.g., aminophylline, adrenaline, ephedrine. However, there is no report on the use of terbutaline for this condition. We have found it quite effective, as in this case. It is a beta-2 stimulator and has relatively little effect upon the heart. In cases without hypotension it seems to be better than adrenaline or ephedrine which may cause a rise in blood pressure and pulse rate. Its onset of action is quicker than aminophylline. For intravenous injection it should be well diluted and given slowly.
